UK markets closed

CymaBay Therapeutics, Inc. (0I5P.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
21.13-0.57 (-2.62%)
At close: 06:09PM GMT
Full screen
Previous close21.70
Bid0.00 x N/A
Ask0.00 x N/A
Day's range21.13 - 21.36
52-week range4.06 - 21.70
Avg. volume2,429
Market cap14.039M
Beta (5Y monthly)0.34
PE ratio (TTM)N/A
EPS (TTM)-1.32
Earnings date07 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    NEWARK, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced the grant of inducement awards to five employees on November 15, 2023 (the “Grant Date”) in connection with the employees’ commencement of employment at CymaBay. The Compensation Committee of the Board of Directors of CymaBay approved the grant of non-quali

  • PR Newswire

    CymaBay Announces an Oral Presentation of Seladelpar Phase 3 Pivotal Results in Primary Biliary Cholangitis at the Late Breaker Session of the Liver Meeting®

    CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that the results from its RESPONSE Phase 3 registration study evaluating seladelpar, a potent, selective, orally-active delpar, or PPAR𝛿 agonist, in adult patients with primary biliary cholangitis (PBC) will be featured as an oral presentation in today's Late Breaker Session of the American Association for the Study of Liver Di

  • Insider Monkey

    CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript

    CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript November 7, 2023 CymaBay Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.32 EPS, expectations were $-0.3. Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Third Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a […]